393 related articles for article (PubMed ID: 19291673)
1. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
Mitsui M; Nishikawa M; Zang L; Ando M; Hattori K; Takahashi Y; Watanabe Y; Takakura Y
J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice.
Nomura T; Yasuda K; Yamada T; Okamoto S; Mahato RI; Watanabe Y; Takakura Y; Hashida M
Gene Ther; 1999 Jan; 6(1):121-9. PubMed ID: 10341884
[TBL] [Abstract][Full Text] [Related]
3. Improved anti-cancer effect of interferon gene transfer by sustained expression using CpG-reduced plasmid DNA.
Kawano H; Nishikawa M; Mitsui M; Takahashi Y; Kako K; Yamaoka K; Watanabe Y; Takakura Y
Int J Cancer; 2007 Jul; 121(2):401-6. PubMed ID: 17372909
[TBL] [Abstract][Full Text] [Related]
4. The effect of CpG motifs on gene expression and clearance kinetics of aerosol administered polyethylenimine (PEI)-plasmid DNA complexes in the lung.
Lesina E; Dames P; Rudolph C
J Control Release; 2010 Apr; 143(2):243-50. PubMed ID: 20074600
[TBL] [Abstract][Full Text] [Related]
5. Plasmidic CpG sequences induce tumor microenvironment modifications in a rat liver metastasis model.
Bertin S; Anjuere F; Gavelli A; Baque P; Soilihi BK; Brossette N; Loubat A; Pierrefite-Carle V
Int J Mol Med; 2008 Mar; 21(3):309-15. PubMed ID: 18288378
[TBL] [Abstract][Full Text] [Related]
6. Sustained exogenous expression of therapeutic levels of IFN-gamma ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization.
Hattori K; Nishikawa M; Watcharanurak K; Ikoma A; Kabashima K; Toyota H; Takahashi Y; Takahashi R; Watanabe Y; Takakura Y
J Immunol; 2010 Mar; 184(5):2729-35. PubMed ID: 20107184
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
Sakurai F; Terada T; Maruyama M; Watanabe Y; Yamashita F; Takakura Y; Hashida M
Cancer Gene Ther; 2003 Sep; 10(9):661-8. PubMed ID: 12944985
[TBL] [Abstract][Full Text] [Related]
8. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs.
Yew NS; Zhao H; Wu IH; Song A; Tousignant JD; Przybylska M; Cheng SH
Mol Ther; 2000 Mar; 1(3):255-62. PubMed ID: 10933941
[TBL] [Abstract][Full Text] [Related]
9. Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery.
Navarro G; Maiwald G; Haase R; Rogach AL; Wagner E; de Ilarduya CT; Ogris M
J Control Release; 2010 Aug; 146(1):99-105. PubMed ID: 20438778
[TBL] [Abstract][Full Text] [Related]
10. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
11. Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes.
Sellins K; Fradkin L; Liggitt D; Dow S
Mol Ther; 2005 Sep; 12(3):451-9. PubMed ID: 15950543
[TBL] [Abstract][Full Text] [Related]
12. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
13. Antimetastatic effect of CpG DNA mediated by type I IFN.
Hafner M; Zawatzky R; Hirtreiter C; Buurman WA; Echtenacher B; Hehlgans T; Männel DN
Cancer Res; 2001 Jul; 61(14):5523-8. PubMed ID: 11454702
[TBL] [Abstract][Full Text] [Related]
14. Hydrodynamic plasmid DNA gene therapy model in liver transplantation.
Tsoulfas G; Takahashi Y; Liu D; Yagnik G; Wu T; Murase N; Geller DA
J Surg Res; 2006 Oct; 135(2):242-9. PubMed ID: 16926028
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice.
Mizuno Y; Naoi T; Nishikawa M; Rattanakiat S; Hamaguchi N; Hashida M; Takakura Y
J Control Release; 2010 Jan; 141(2):252-9. PubMed ID: 19778560
[TBL] [Abstract][Full Text] [Related]
16. Bacterial DNA methylation and gene transfer efficiency.
Allamane S; Jourdes P; Ratel D; Vicat JM; Dupré I; Lainé M; Berger F; Benabid AL; Wion D
Biochem Biophys Res Commun; 2000 Oct; 276(3):1261-4. PubMed ID: 11027620
[TBL] [Abstract][Full Text] [Related]
17. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.
Wu A; Oh S; Ericson K; Demorest ZL; Vengco I; Gharagozlou S; Chen W; Low WC; Ohlfest JR
Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381
[TBL] [Abstract][Full Text] [Related]
18. High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine.
Tada M; Hatano E; Taura K; Nitta T; Koizumi N; Ikai I; Shimahara Y
J Gene Med; 2006 Aug; 8(8):1018-26. PubMed ID: 16779866
[TBL] [Abstract][Full Text] [Related]
19. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.
Hyde SC; Pringle IA; Abdullah S; Lawton AE; Davies LA; Varathalingam A; Nunez-Alonso G; Green AM; Bazzani RP; Sumner-Jones SG; Chan M; Li H; Yew NS; Cheng SH; Boyd AC; Davies JC; Griesenbach U; Porteous DJ; Sheppard DN; Munkonge FM; Alton EW; Gill DR
Nat Biotechnol; 2008 May; 26(5):549-51. PubMed ID: 18438402
[TBL] [Abstract][Full Text] [Related]
20. Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway.
Schwartz DA; Wohlford-Lenane CL; Quinn TJ; Krieg AM
J Immunol; 1999 Jul; 163(1):224-31. PubMed ID: 10384120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
